Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_assertion description "[Therefore, we evaluated the feasibility of intracavitary injection of E1A gene complexed with DC-Chol cationic liposome (DCC-E1A) in patients with both HER-2/neu-overexpressing and low HER-2/neu-expressing breast and ovarian cancers in a phase I clinical trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_assertion evidence source_evidence_literature NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_assertion SIO_000772 11454891 NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_assertion wasDerivedFrom befree-20150227 NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_assertion wasGeneratedBy ECO_0000203 NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.
- befree-20150227 importedOn "2015-02-27" NP348062.RAaNV1F7TdVFWh0fhgRYrP6CmewwkNN6j4eHx18SIf2as130_provenance.